Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
CALL
Camping World
CWH
$666M
| $750K | ﹤0.01% |
35,200
+29,400
| +507% | +$647K |
|
3852
InterContinental Hotels
IHG
$23.6B
| $750K | ﹤0.01% |
11,348
| – | – |
|
3853
ICL Group
ICL
$7.15B
| $748K | ﹤0.01% |
123,970
+97,361
| +366% | +$516K |
|
3854
Quanex
NX
$963M
| $748K | ﹤0.01% |
41,085
+28,265
| +220% | +$498K |
|
|
DMC
3855
Del Monte Corp
DMC
$1.44B
| $747K | ﹤0.01% |
22,010
-6,384
| -22% | -$250K |
|
3856
CALL
Melco Resorts & Entertainment
MLCO
$2.14B
| $747K | ﹤0.01% |
35,300
-107,800
| -75% | -$2.5M |
|
3857
CALL
Trupanion
TRUP
$1.36B
| $747K | ﹤0.01% |
20,900
+11,900
| +132% | +$459K |
|
|
3858
PUT
Trupanion
TRUP
$1.36B
| $747K | ﹤0.01% |
20,900
-21,900
| -51% | -$845K |
|
|
CUTR
3859
DELISTED
Cutera, Inc.
CUTR
| $746K | ﹤0.01% |
22,891
+14,210
| +164% | +$518K |
|
3860
CALL
Sunoco
SUN
$14.2B
| $745K | ﹤0.01% |
25,200
+23,800
| +1,700% | +$641K |
|
3861
Artisan Partners
APAM
$3B
| $743K | ﹤0.01% |
22,908
+19,390
| +551% | +$632K |
|
|
TTM
3862
CALL
DELISTED
Tata Motors Limited
TTM
| $743K | ﹤0.01% |
48,400
+25,800
| +114% | +$474K |
|
3863
CALL
iShares Core S&P Small-Cap ETF
IJR
$114B
| $742K | ﹤0.01% |
8,500
-12,000
| -59% | -$1.05M |
|
3864
National Healthcare
NHC
$3.48B
| $741K | ﹤0.01% |
9,824
+8,938
| +1,009% | +$658K |
|
3865
RPC Inc
RES
$1.42B
| $741K | ﹤0.01% |
47,876
+2,585
| +6% | +$38K |
|
|
FG
3866
DELISTED
FGL Holdings Ordinary Shares
FG
| $741K | ﹤0.01% |
82,783
-34,753
| -30% | -$310K |
|
3867
Motorcar Parts of America
MPAA
$234M
| $739K | ﹤0.01% |
31,510
+24,536
| +352% | +$571K |
|
3868
Weis Markets
WMK
$1.74B
| $739K | ﹤0.01% |
17,042
+8,351
| +96% | +$406K |
|
3869
PUT
CACI
CACI
$14.8B
| $737K | ﹤0.01% |
+4,000
| New | +$738K |
|
|
WCG
3870
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $737K | ﹤0.01% |
2,300
+1,700
| +283% | +$483K |
|
3871
CALL
Pultegroup
PHM
$24.8B
| $736K | ﹤0.01% |
29,700
-13,000
| -30% | -$368K |
|
3872
CALL
Assured Guaranty
AGO
$3.35B
| $735K | ﹤0.01% |
17,400
-2,300
| -12% | -$91.3K |
|
|
GES
3873
PUT
DELISTED
Guess Inc
GES
| $735K | ﹤0.01% |
32,500
-900
| -3% | -$20.4K |
|
3874
Insmed
INSM
$27.1B
| $734K | ﹤0.01% |
36,281
+6,295
| +21% | +$142K |
|
3875
Amphastar Pharmaceuticals
AMPH
$857M
| $733K | ﹤0.01% |
38,112
+19,823
| +108% | +$353K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.